Enzyme-responsive nanoparticles for drug release and diagnostics

Roberto De La Rica, Daniel Aili, Molly Stevens

Research output: Contribution to journalLiterature review

325 Citations (Scopus)

Abstract

Enzymes are key components of the bionanotechnology toolbox that possess exceptional biorecognition capabilities and outstanding catalytic properties. When combined with the unique physical properties of nanomaterials, the resulting enzyme-responsive nanoparticles can be designed to perform functions efficiently and with high specificity for the triggering stimulus. This powerful concept has been successfully applied to the fabrication of drug delivery schemes where the tissue of interest is targeted via release of cargo triggered by the biocatalytic action of an enzyme. Moreover, the chemical transformation of the carrier by the enzyme can also generate therapeutic molecules, therefore paving the way to design multimodal nanomedicines with synergistic effects. Dysregulation of enzymatic activity has been observed in a number of severe pathological conditions, and this observation is useful not only to program drug delivery in vivo but also to fabricate ultrasensitive sensors for diagnosing these diseases. In this review, several enzyme-responsive nanomaterials such as polymer-based nanoparticles, liposomes, gold nanoparticles and quantum dots are introduced, and the modulation of their physicochemical properties by enzymatic activity emphasized. When known, toxicological issues related to the utilization nanomaterials are highlighted. Key examples of enzyme-responsive nanomaterials for drug delivery and diagnostics are presented, classified by the type of effector biomolecule, including hydrolases such as proteases, lipases and glycosidases, and oxidoreductases.
LanguageEnglish
Pages967-978
Number of pages12
JournalAdvanced Drug Delivery Reviews
Volume64
Issue number11
DOIs
Publication statusPublished - Aug 2012

Fingerprint

Nanoparticles
enzymes
drugs
Nanostructures
nanoparticles
Enzymes
delivery
Pharmaceutical Preparations
Nanomedicine
effectors
Quantum Dots
protease
cargo
Glycoside Hydrolases
Hydrolases
Lipase
Liposomes
Gold
Toxicology
stimuli

Keywords

  • diagnostics
  • drug release
  • enzyme-responsive nanoparticles
  • smart materials
  • nanomedicine
  • enzyme
  • drug delivery
  • biosensor
  • sensor
  • nanobiotechnology
  • theragnostics
  • cancer
  • stimuli-responsive

Cite this

De La Rica, Roberto ; Aili, Daniel ; Stevens, Molly. / Enzyme-responsive nanoparticles for drug release and diagnostics. In: Advanced Drug Delivery Reviews. 2012 ; Vol. 64, No. 11. pp. 967-978.
@article{97324262d79f40b9a9f274be3c257d19,
title = "Enzyme-responsive nanoparticles for drug release and diagnostics",
abstract = "Enzymes are key components of the bionanotechnology toolbox that possess exceptional biorecognition capabilities and outstanding catalytic properties. When combined with the unique physical properties of nanomaterials, the resulting enzyme-responsive nanoparticles can be designed to perform functions efficiently and with high specificity for the triggering stimulus. This powerful concept has been successfully applied to the fabrication of drug delivery schemes where the tissue of interest is targeted via release of cargo triggered by the biocatalytic action of an enzyme. Moreover, the chemical transformation of the carrier by the enzyme can also generate therapeutic molecules, therefore paving the way to design multimodal nanomedicines with synergistic effects. Dysregulation of enzymatic activity has been observed in a number of severe pathological conditions, and this observation is useful not only to program drug delivery in vivo but also to fabricate ultrasensitive sensors for diagnosing these diseases. In this review, several enzyme-responsive nanomaterials such as polymer-based nanoparticles, liposomes, gold nanoparticles and quantum dots are introduced, and the modulation of their physicochemical properties by enzymatic activity emphasized. When known, toxicological issues related to the utilization nanomaterials are highlighted. Key examples of enzyme-responsive nanomaterials for drug delivery and diagnostics are presented, classified by the type of effector biomolecule, including hydrolases such as proteases, lipases and glycosidases, and oxidoreductases.",
keywords = "diagnostics, drug release, enzyme-responsive nanoparticles, smart materials, nanomedicine, enzyme, drug delivery, biosensor, sensor, nanobiotechnology, theragnostics, cancer, stimuli-responsive",
author = "{De La Rica}, Roberto and Daniel Aili and Molly Stevens",
year = "2012",
month = "8",
doi = "10.1016/j.addr.2012.01.002",
language = "English",
volume = "64",
pages = "967--978",
journal = "Advanced Drug Delivery Reviews",
issn = "0169-409X",
number = "11",

}

Enzyme-responsive nanoparticles for drug release and diagnostics. / De La Rica, Roberto; Aili, Daniel; Stevens, Molly.

In: Advanced Drug Delivery Reviews, Vol. 64, No. 11, 08.2012, p. 967-978.

Research output: Contribution to journalLiterature review

TY - JOUR

T1 - Enzyme-responsive nanoparticles for drug release and diagnostics

AU - De La Rica, Roberto

AU - Aili, Daniel

AU - Stevens, Molly

PY - 2012/8

Y1 - 2012/8

N2 - Enzymes are key components of the bionanotechnology toolbox that possess exceptional biorecognition capabilities and outstanding catalytic properties. When combined with the unique physical properties of nanomaterials, the resulting enzyme-responsive nanoparticles can be designed to perform functions efficiently and with high specificity for the triggering stimulus. This powerful concept has been successfully applied to the fabrication of drug delivery schemes where the tissue of interest is targeted via release of cargo triggered by the biocatalytic action of an enzyme. Moreover, the chemical transformation of the carrier by the enzyme can also generate therapeutic molecules, therefore paving the way to design multimodal nanomedicines with synergistic effects. Dysregulation of enzymatic activity has been observed in a number of severe pathological conditions, and this observation is useful not only to program drug delivery in vivo but also to fabricate ultrasensitive sensors for diagnosing these diseases. In this review, several enzyme-responsive nanomaterials such as polymer-based nanoparticles, liposomes, gold nanoparticles and quantum dots are introduced, and the modulation of their physicochemical properties by enzymatic activity emphasized. When known, toxicological issues related to the utilization nanomaterials are highlighted. Key examples of enzyme-responsive nanomaterials for drug delivery and diagnostics are presented, classified by the type of effector biomolecule, including hydrolases such as proteases, lipases and glycosidases, and oxidoreductases.

AB - Enzymes are key components of the bionanotechnology toolbox that possess exceptional biorecognition capabilities and outstanding catalytic properties. When combined with the unique physical properties of nanomaterials, the resulting enzyme-responsive nanoparticles can be designed to perform functions efficiently and with high specificity for the triggering stimulus. This powerful concept has been successfully applied to the fabrication of drug delivery schemes where the tissue of interest is targeted via release of cargo triggered by the biocatalytic action of an enzyme. Moreover, the chemical transformation of the carrier by the enzyme can also generate therapeutic molecules, therefore paving the way to design multimodal nanomedicines with synergistic effects. Dysregulation of enzymatic activity has been observed in a number of severe pathological conditions, and this observation is useful not only to program drug delivery in vivo but also to fabricate ultrasensitive sensors for diagnosing these diseases. In this review, several enzyme-responsive nanomaterials such as polymer-based nanoparticles, liposomes, gold nanoparticles and quantum dots are introduced, and the modulation of their physicochemical properties by enzymatic activity emphasized. When known, toxicological issues related to the utilization nanomaterials are highlighted. Key examples of enzyme-responsive nanomaterials for drug delivery and diagnostics are presented, classified by the type of effector biomolecule, including hydrolases such as proteases, lipases and glycosidases, and oxidoreductases.

KW - diagnostics

KW - drug release

KW - enzyme-responsive nanoparticles

KW - smart materials

KW - nanomedicine

KW - enzyme

KW - drug delivery

KW - biosensor

KW - sensor

KW - nanobiotechnology

KW - theragnostics

KW - cancer

KW - stimuli-responsive

UR - http://www.journals.elsevier.com/advanced-drug-delivery-reviews

U2 - 10.1016/j.addr.2012.01.002

DO - 10.1016/j.addr.2012.01.002

M3 - Literature review

VL - 64

SP - 967

EP - 978

JO - Advanced Drug Delivery Reviews

T2 - Advanced Drug Delivery Reviews

JF - Advanced Drug Delivery Reviews

SN - 0169-409X

IS - 11

ER -